Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Repeated dose toxicity: other routes

Currently viewing:

Administrative data

Endpoint:
repeated dose toxicity: other route
Remarks:
other: 3 days
Type of information:
experimental study
Adequacy of study:
other information
Reliability:
4 (not assignable)
Rationale for reliability incl. deficiencies:
other: Summary report

Data source

Reference
Reference Type:
publication
Title:
Actions & interactions: Glycidyl ethers.
Author:
Lane JM
Year:
1980
Bibliographic source:
Veterinary and human toxicology 22(2): 99-101

Materials and methods

Principles of method if other than guideline:
Male rats were exposued to allyl glycidyl ether via intramuscular injections (400 mg/kg bw) on 3 consecutive days and subjected to lymphoid tissue examination.
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
Allyl 2,3-epoxypropyl ether
EC Number:
203-442-4
EC Name:
Allyl 2,3-epoxypropyl ether
Cas Number:
106-92-3
Molecular formula:
C6H10O2
IUPAC Name:
2-[(prop-2-en-1-yloxy)methyl]oxirane
Details on test material:
- Name of test material (as cited in study report): Allyl Glycidyl Ether

Test animals

Species:
rat
Strain:
not specified
Sex:
male

Administration / exposure

Route of administration:
intramuscular
Vehicle:
not specified
Duration of treatment / exposure:
3 days
Frequency of treatment:
once daily
Doses / concentrations
Remarks:
Doses / Concentrations:
400 mg/kg bw
No. of animals per sex per dose:
3
Control animals:
not specified

Results and discussion

Target system / organ toxicity

Critical effects observed:
not specified

Any other information on results incl. tables

2 out of 3 showed atrophy or loss of lymphoid tissue and decreased leucocyte count. The same report summarized results for other glycidyl ethers showing similar results indicating a class effect.

Applicant's summary and conclusion